"L\u00E9\u010Dba metastatick\u00E9ho ren\u00E1ln\u00EDho karcinomu v \u010Cesk\u00E9 republice podle datab\u00E1ze RENIS"@cs . . . "Soub\u011B\u017En\u00FD n\u00E1zev"@en . "CZ - \u010Cesk\u00E1 republika" . "1801-1209" . "L\u00E9\u010Dba metastatick\u00E9ho ren\u00E1ln\u00EDho karcinomu v \u010Cesk\u00E9 republice podle datab\u00E1ze RENIS"@cs . "B\u00FCchler, Tom\u00E1\u0161" . . "9" . "Soub\u011B\u017En\u00FD n\u00E1zev"@en . "Therapy of metastatic renal cell carcinoma (mRCC) with targeted inhibitors of key cellular processes is a relative new option for systemic treatment. Its optimum use requires, among others, a thorough analysis of the results obtained in routine clinical practice. These data for the Czech Republic are collected in the RENIS database."@en . "metastatic renal cell carcinoma; mRCC; RENIS database; targeted therapy; sunitinib; sorafenib; pazopanib; bevacizumab; temsirolimus; everolimus"@en . "2" . . "1"^^ . . . . "V" . . "84551" . . "Terapie metastatick\u00E9ho ren\u00E1ln\u00EDho karcinomu (mRCC) c\u00EDlen\u00FDmi inhibitory kl\u00ED\u010Dov\u00FDch bun\u011B\u010Dn\u00FDch proces\u016F je pom\u011Brn\u011B novou mo\u017Enost\u00ED syst\u00E9mov\u00E9 l\u00E9\u010Dby. Jej\u00ED optim\u00E1ln\u00ED vyu\u017Eit\u00ED vy\u017Eaduje krom\u011B jin\u00E9ho d\u016Fkladnou anal\u00FDzu v\u00FDsledk\u016F dosahovan\u00FDch v b\u011B\u017En\u00E9 klinick\u00E9 praxi. Tyto \u00FAdaje pro \u010Ceskou republiku shroma\u017E\u010Fuje datab\u00E1ze RENIS."@cs . "1"^^ . "5"^^ . "Farmakoterapie" . . "L\u00E9\u010Dba metastatick\u00E9ho ren\u00E1ln\u00EDho karcinomu v \u010Cesk\u00E9 republice podle datab\u00E1ze RENIS" . "RIV/00064190:_____/13:#0000689!RIV14-MZ0-00064190" . . . . . . . "[C562E240777C]" . . . "L\u00E9\u010Dba metastatick\u00E9ho ren\u00E1ln\u00EDho karcinomu v \u010Cesk\u00E9 republice podle datab\u00E1ze RENIS" . . "Terapie metastatick\u00E9ho ren\u00E1ln\u00EDho karcinomu (mRCC) c\u00EDlen\u00FDmi inhibitory kl\u00ED\u010Dov\u00FDch bun\u011B\u010Dn\u00FDch proces\u016F je pom\u011Brn\u011B novou mo\u017Enost\u00ED syst\u00E9mov\u00E9 l\u00E9\u010Dby. Jej\u00ED optim\u00E1ln\u00ED vyu\u017Eit\u00ED vy\u017Eaduje krom\u011B jin\u00E9ho d\u016Fkladnou anal\u00FDzu v\u00FDsledk\u016F dosahovan\u00FDch v b\u011B\u017En\u00E9 klinick\u00E9 praxi. Tyto \u00FAdaje pro \u010Ceskou republiku shroma\u017E\u010Fuje datab\u00E1ze RENIS." . . . . "RIV/00064190:_____/13:#0000689" .